✦ LIBER ✦

Improving cardiovascular risk – applying evidence-based medicine to glucose-lowering therapy with thiazolidinediones in patients with type 2 diabetes

✍ Scribed by M. Fisher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiologist’s Role in Improving Glucose

✍ Antonio M. Gotto Jr. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Initiating oral glucose-lowering therapy

✍ A Consoli; R Gomis; S Halimi; PD Home; H Mehnert; K Strojek; LF Van Gaal 📂 Article 📅 2004 🏛 Masson Editeur 🌐 French ⚖ 141 KB

Delayed initiation of subcutaneous insul

✍ A. Rubino; L. J. McQuay; S. C. Gough; M. Kvasz; P. Tennis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

In navigator, the angiotensin receptor b

✍ Michael J. Bloch; Jan N. Basile 📂 Article 📅 2010 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB

Use of intensified comprehensive cardiac

✍ Anne Merete Boas Soja; Ann-Dorthe Olsen Zwisler; Marianne Frederiksen; Thomas Me 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Transferring to insulin detemir from NPH

✍ A. Dornhorst; H.-J. Lüddeke; C. Koenen; M. Meriläinen; A. King; A. Robinson; S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB